Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Depreciation and Depletion (2017 - 2025)

Historic Depreciation and Depletion for Selectis Health (GBCS) over the last 11 years, with Q3 2025 value amounting to $364699.0.

  • Selectis Health's Depreciation and Depletion fell 251.77% to $364699.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 403.27%. This contributed to the annual value of $1.7 million for FY2023, which is 706.37% down from last year.
  • Selectis Health's Depreciation and Depletion amounted to $364699.0 in Q3 2025, which was down 251.77% from $374118.0 recorded in Q3 2024.
  • Over the past 5 years, Selectis Health's Depreciation and Depletion peaked at $1.7 million during Q1 2021, and registered a low of -$447070.0 during Q3 2021.
  • Its 5-year average for Depreciation and Depletion is $450955.7, with a median of $438730.0 in 2023.
  • Examining YoY changes over the last 5 years, Selectis Health's Depreciation and Depletion showed a top increase of 36600.41% in 2021 and a maximum decrease of 21528.87% in 2021.
  • Quarter analysis of 5 years shows Selectis Health's Depreciation and Depletion stood at $447070.0 in 2021, then decreased by 0.64% to $444195.0 in 2022, then fell by 3.03% to $430754.0 in 2023, then dropped by 13.15% to $374118.0 in 2024, then dropped by 2.52% to $364699.0 in 2025.
  • Its last three reported values are $364699.0 in Q3 2025, $374118.0 for Q3 2024, and $409530.0 during Q2 2024.